Dupont Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,891
| Closed | -$312K | – | 1678 |
|
|
2022
Q2 | $312K | Hold |
12,891
| – | – | 0.01% | 849 |
|
|
2022
Q1 | $332K | Sell |
12,891
-1,141
| -8% | -$29.4K | 0.01% | 896 |
|
|
2021
Q4 | $436K | Sell |
14,032
-5,595
| -29% | -$174K | 0.02% | 858 |
|
|
2021
Q3 | $476K | Sell |
19,627
-2,774
| -12% | -$67.3K | 0.02% | 914 |
|
|
2021
Q2 | $327K | Hold |
22,401
| – | – | 0.01% | 1169 |
|
|
2021
Q1 | $559K | Sell |
22,401
-4,594
| -17% | -$115K | 0.01% | 866 |
|
|
2020
Q4 | $736K | Sell |
26,995
-2,015
| -7% | -$54.9K | 0.02% | 686 |
|
|
2020
Q3 | $536K | Buy |
29,010
+9,496
| +49% | +$175K | 0.01% | 718 |
|
|
2020
Q2 | $398K | Sell |
19,514
-1,743
| -8% | -$35.6K | 0.01% | 871 |
|
|
2020
Q1 | $310K | Buy |
+21,257
| New | +$310K | 0.01% | 847 |
|
|
2016
Q4 | – | Sell |
-38,018
| Closed | -$851K | – | 870 |
|
|
2016
Q3 | $851K | Buy |
+38,018
| New | +$851K | 0.02% | 490 |
|